🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Guangzhou
Clinical trial register · China

Clinical Trials in Guangzhou

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University451 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University181 Nanfang Hospital, Southern Medical University138 AstraZeneca133 Guangdong Provincial People's Hospital81
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
3318 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Peripartum Mental Health Cohort Study in Guangzhou
NCT04499066Depression, Anxiety
Guangzhou Women and Children's Medical Center
Observational
3,000
Guangzhou
2012-02-01
Recruiting
Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study
NCT03742011PCOS, Offspring, Adult, Hyperandrogenism, Epigenetics
Guangzhou Women and Children's Medical Center
Observational
2,000
Guangzhou
2012-02-01
Recruiting
GDM and Its Consequences in Mothers and Offsprings
NCT04529889Gestational Diabetes Mellitus, Pregnancy Outcome, Neurodevelopment, Immune Development
Guangzhou Women and Children's Medical Center
Observational
7,000
Guangzhou
2012-02-01
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Nanning, Chengdu, Beijing, Dalian, Guangzhou, Hangzhou, Harbin, Kunming
2012-01
Recruiting
A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC
NCT03303495Colorectal Neoplasms, Neoplasm Metastasis, Intestinal Neoplasms, Gastrointestinal Neoplasms
Sun Yat-sen University
Phase 3
280
Guangzhou
2011-11-14
Recruiting
International Big Data Centre in Emergency Medicine
NCT05616416Emergency Medicine
Guangdong Provincial People's Hospital
Observational
500,000
Guangzhou
2011-01-01
Recruiting
Epidemiological Insights Into the Formation, Progression, and Rupture of Intracranial Aneurysms: A Retrospective, Multi-Center Hospital-Based Study in China
NCT06456814Intracranial Aneurysm, Subarachnoid Hemorrhage, Aneurysmal, Cerebral Aneurysm, Brain Aneurysm
Zhujiang Hospital
Observational
30,000
Guangzhou
2010-01-01
Recruiting
Observational Study on Patients With HIV/AIDS(OSPWH)
NCT04667026HIV Infections
Guangzhou 8th People's Hospital
Observational
15,000
Guangzhou
2009-01-01
Active, closed
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
NCT00781612Neoplasm Metastasis
Genentech, Inc.
Phase 2
378
Beijing, Changchun, Guangzhou, Hangzhou, Harbin, Nanjing, Shanghai
2008-10-16
Recruiting
Insights Into Pediatric Pulmonary Hypertension: A Real-World Registry of Epidemiology and Outcomes
NCT07495774Pulmonary Hypertension
Guangdong Provincial People's Hospital
Observational
450
Guangzhou
2006-01-04
Recruiting
The New Serial Treatment of Temporomandibular Disorders
NCT00932594Temporomandibular Disorder
Sun Yat-sen University
Not applicable
4
Guangzhou
2006-01
Recruiting
Nutrition Support on Outcomes and Cost-effectiveness for Patients at Risk
NCT00289380Malnutrition, Nutritional Risk
Peking Union Medical College
Observational
2,000
Beijing, Chongqing, Guangzhou, Nanning, Shijiazhuang, Tianjin, Wuhan, Nanjing
2005-01
Recruiting
Pompe Disease Registry Protocol
NCT00231400Glycogen Storage Disease Type II, Pompe Disease
Genzyme, a Sanofi Company
Observational
2,000
Beijing, Guangzhou, Jinan, Shanghai
2004-09-15
Recruiting
The Chinese Pulmonary Lymphoepithelioma-like Carcinoma Collaboration Study
NCT06801977Primary Pulmonary Lymphoepithelioma-like Carcinoma
Sun Yat-sen University
Observational
10,000
Foshan, Guangzhou
2002-01-01
Recruiting
Association of Inpatient Blood Pressure Levels With In-hospital Adverse Events(APPLE Study)
NCT04226612Blood Pressure
Guangdong Provincial People's Hospital
Observational
100,000
Guangzhou
2000-01-01
Recruiting
High Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)
NCT06682507Lupus Nephritis (LN)
First Affiliated Hospital, Sun Yat-Sen University
Observational
5,000
Guangzhou
1996-01-01
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Beijing, Guangzhou, Hangzhou, Nanjing, Shanghai
1991-04-01
Recruiting
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
NCT00271180Arrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia
Medtronic
Observational
20,000
Beijing, Changsha, Dalian, Fuzhou, Guangzhou, Hangzhou, Harbin, Kunming
1983-01
Rows per page Showing 3301–3318 of 3318
Previous 32 33 34
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/guangzhou?page=34

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.